Jan Š.
- Country
- Czechia
- Department
- NA
Research Overview
- Phase III Study of RO7795068 in Adults With Obesity or Overweight and Type 2 Diabetes
- Randomized Study of Cagrilintide + Semaglutide Combination vs Semaglutide Monotherapy for Weight Loss in Adults with Obesity (± Type 2 Diabetes)
- A single arm study investigating the glycaemic control and safety of adding semaglutide to insulin icodec in participants with type 2 diabetes qualifying for treatment intensification.
Data & Insights
Has run more than one trial at 14 of 190 partner sites.
Specializations
Type 2 Diabetes
Jan Šoupal’s clinical research activity includes type 2 diabetes care in a diabetology outpatient clinic setting in Prague, with a focus on improving glycaemic control through treatment strategies that combine basal insulin therapy with GLP-1 receptor agonist support.
- Blood glucose regulation
- Insulin intensification
- Combination therapy in diabetes
His work in this area aligns with clinical interests in optimizing metabolic management for people living with persistent hyperglycaemia.
Obesity and Overweight
His trial portfolio also covers obesity and overweight in the context of type 2 diabetes, with attention to body weight reduction and broader metabolic risk management.
- Weight management
- Body mass reduction
- Metabolic risk control
This area reflects a therapeutic interest in addressing excess adiposity alongside diabetic disease burden.
Metabolic Therapy Innovation
Jan Šoupal is involved in clinical evaluation of emerging metabolic therapies intended to support both glucose lowering and weight control, with relevance to patients whose diabetes is complicated by excess body weight.
- Novel antidiabetic treatment
- Integrated metabolic care
- Cardiometabolic disease management
His research setting spans two affiliated sites, Comfort Care a.s. and FLEDIP s.r.o., both contributing to his clinical focus in Prague.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.